Logo image of ATRI

ATRION CORPORATION (ATRI) Stock Price, Quote, News and Overview

NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD

459.92  +0.26 (+0.06%)

ATRI Quote, Performance and Key Statistics

ATRION CORPORATION

NASDAQ:ATRI (8/20/2024, 8:22:19 PM)

459.92

+0.26 (+0.06%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High503.24
52 Week Low274.98
Market Cap809.46M
Shares1.76M
Float960.00K
Yearly Dividend8.6
Dividend Yield1.91%
PE64.5
Fwd PEN/A
Earnings (Next)11-05 2024-11-05/amc
IPO03-18 1980-03-18


ATRI short term performance overview.The bars show the price performance of ATRI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

ATRI long term performance overview.The bars show the price performance of ATRI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30

The current stock price of ATRI is 459.92 USD. In the past month the price increased by 0.48%. In the past year, price increased by 0.88%.

ATRION CORPORATION / ATRI Daily stock chart

ATRI Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ALC ALCON INC 29.9 45.13B
COO COOPER COS INC/THE 23.91 17.66B
ALGN ALIGN TECHNOLOGY INC 20.39 14.22B
SOLV SOLVENTUM CORP 17.55 12.61B
MMSI MERIT MEDICAL SYSTEMS INC 30.7 6.01B
BLCO BAUSCH + LOMB CORP 25.4 5.55B
LNTH LANTHEUS HOLDINGS INC 11.27 5.44B
ICUI ICU MEDICAL INC 27.69 3.85B
XRAY DENTSPLY SIRONA INC 10.14 3.73B
HAE HAEMONETICS CORP/MASS 14.9 3.17B
NEOG NEOGEN CORP 25.1 2.18B
UFPT UFP TECHNOLOGIES INC 36.31 1.95B

About ATRI

Company Profile

ATRI logo image Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Company Info

ATRION CORPORATION

One Allentown Parkway

Allen TEXAS 75002 US

CEO: David A. Battat

Employees: 712

Company Website: https://atrioncorp.com/

Phone: 19723909800

ATRION CORPORATION / ATRI FAQ

What is the stock price of ATRION CORPORATION today?

The current stock price of ATRI is 459.92 USD. The price increased by 0.06% in the last trading session.


What is the ticker symbol for ATRION CORPORATION stock?

The exchange symbol of ATRION CORPORATION is ATRI and it is listed on the Nasdaq exchange.


On which exchange is ATRI stock listed?

ATRI stock is listed on the Nasdaq exchange.


What is ATRION CORPORATION worth?

ATRION CORPORATION (ATRI) has a market capitalization of 809.46M USD. This makes ATRI a Small Cap stock.


How many employees does ATRION CORPORATION have?

ATRION CORPORATION (ATRI) currently has 712 employees.


What are the support and resistance levels for ATRION CORPORATION (ATRI) stock?

ATRION CORPORATION (ATRI) has a support level at 459.27 and a resistance level at 465.26. Check the full technical report for a detailed analysis of ATRI support and resistance levels.


Should I buy ATRION CORPORATION (ATRI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ATRION CORPORATION (ATRI) stock pay dividends?

ATRION CORPORATION (ATRI) has a dividend yield of 1.91%. The yearly dividend amount is currently 8.6. Check the full fundamental report for a detailed analysis of ATRI dividend history, reliability and sustainability.


When does ATRION CORPORATION (ATRI) report earnings?

ATRION CORPORATION (ATRI) will report earnings on 2024-11-05, after the market close.


What is the Price/Earnings (PE) ratio of ATRION CORPORATION (ATRI)?

The PE ratio for ATRION CORPORATION (ATRI) is 64.5. This is based on the reported non-GAAP earnings per share of 7.13 and the current share price of 459.92 USD. Check the full fundamental report for a full analysis of the valuation metrics for ATRI.


ATRI Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ATRI. When comparing the yearly performance of all stocks, ATRI is a bad performer in the overall market: 67.28% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ATRI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ATRI. ATRI has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATRI Financial Highlights

Over the last trailing twelve months ATRI reported a non-GAAP Earnings per Share(EPS) of 7.13. The EPS decreased by -53.54% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.92%
ROA 4.82%
ROE 5.26%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-93.89%
Sales Q2Q%11.25%
EPS 1Y (TTM)-53.54%
Revenue 1Y (TTM)6%

ATRI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 40% to ATRI. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners1.01%
Ins Owners1.03%
Short Float %N/A
Short RatioN/A
Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A